Postoperative cognitive outcome was significantly better in patients with intraoperative cerebral oximetry monitoring. Prolonged rSO2 desaturation is a predictor of cognitive decline and has to be avoided.

In this study, the authors examined the preferred interpersonal distances of individuals with combat-related posttraumatic stress disorder (PTSD). Study participants were 151 male war veterans, of whom 83 were suffering from PTSD and 68 were not suffering from PTSD symptoms (control group). Personal space was assessed using a stop-distance technique, where male and female research assistants approached the participants from four directions. Participants with PTSD preferred significantly larger interpersonal distances than did the control group. Participants in both groups maintained larger interpersonal distances when approached by a man than by a woman. The PTSD participants preferred the greatest interpersonal distance when approached from behind, whereas the control group preferred the greatest distance when approached frontally. The authors found these results to be consistent with the self-protective function of personal space.

The aim of this study was to examine the importance of Yalom’s therapeutic factors in psychodynamic group psychotherapy based on the duration of patients’ participation in the group and their sociodemographic characteristics. A total of 57 outpatients with psychosis completed Yalom’s therapeutic factors questionnaire, and were divided into four groups according to the duration of their participation in the group. The instillation of hope, group cohesiveness and existential factors were the highest ranking, whereas identification was the lowest ranking therapeutic factor. Longer participation in the group was associated with greater perceived importance of catharsis and family re-enactment factors. The relationship between the perceived importance of the therapeutic factors and the participant’s gender, age, and level of education was examined. The findings of this study may contribute to an improved understanding of group processes in patients with psychosis, and may assist with the development of more effective therapeutic approaches in this population.

BackgroundThe Sveti Ivan Psychiatric Hospital in Zagreb, Croatia, offers foster home care treatment that includes pharmacotherapy, group psychodynamic psychotherapy, family therapy, and work and occupational therapy. The aim of this study is to compare the health-related quality of life of patients with schizophrenia treated in foster home care with that of patients in standard outpatient treatment.MethodsThe sample consisted of 44 patients with schizophrenia who, upon discharge from the hospital, were included in foster home care treatment and a comparative group of 50 patients who returned to their families and continued receiving outpatient treatment. All patients completed the Short Form 36 Health Survey Questionnaire on the day they completed hospital treatment, 6 months later, and 1 year after they participated in the study. The research also included data on the number of hospitalizations for both groups of patients.ResultsThough directly upon discharge from the hospital, patients who entered foster home care treatment assessed their health-related quality of life as poorer than patients who returned to their families, their assessments significantly improved over time. After 6 months of treatment, these patients even achieved better results in several dimensions than did patients in the outpatient program, and they also had fewer hospitalizations. These effects remained the same at the follow-up 1 year after the inclusion in the study.ConclusionNotwithstanding the limitations of this study, it can be concluded that treatment in foster home care is associated with an improvement in the quality of life of patients with schizophrenia, but the same was not observed for the patients in standard outpatient treatment. We hope that these findings will contribute to an improved understanding of the influence of psychosocial factors on the functioning of patients and the development of more effective therapeutic methods aimed at improving the patients’ quality of life.

Background: Primary pulmonary hypertension is a rare, debilitating disease with a poor prognosis and few treatment options. Long‐term intravenous epoprostenol is used in adults but there is limited experience in paediatric patients. Aim: To describe the program for the administration of epoprostenol for children and adolescents at the Royal Children's Hospital. Method: A protocol for assessment, treatment, education and monitoring of patients was developed by the cardiology and pharmacy departments. Epoprostenol is given through a central venous line via a portable infusion pump with a 100 mL medication cassette. Infusions are commenced in Intensive Care and training is provided in a cardiac ward. Regular outpatient review and dosage increments are required. Results: Home infusions of epoprostenol have been established in three patients. Conclusion: Long‐term epoprostenol treatment is complex and expensive. Beraprost, an orally active prostacyclin analogue, may be an alternative therapy in some patients with less severe disease.